| http://www.w3.org/ns/prov#value | - ership position in SMAC mimetics, TetraLogic is at the forefront of discovering and developing a new class of cancer therapies that are demonstrating the potential to overcome the limitations of current anticancer therapies.TetraLogic's birinapant could become a blockbuster drug as a potential treatment for solid tumors and hematological malignancies, as well as viral infections such as hepatitis
|
